Skip to main
G
G logo

Genpact (G) Stock Forecast & Price Target

Genpact (G) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 0%
Hold 71%
Sell 0%
Strong Sell 0%

Bulls say

Genpact Ltd is positioned for strong performance, supported by solid low-double-digit revenue growth expectations driven by robust bookings momentum and a focus on expanding margins. The company's strategic emphasis on core business process management and advanced technology solutions is anticipated to further enhance its growth trajectory, with projections for revenue growth of over 7% and advanced technology solutions expanding by 15%+. Additionally, as macroeconomic conditions stabilize, Genpact is expected to benefit from a healthy deal pipeline and increasing demand for AI-based solutions, thus solidifying its positive financial outlook.

Bears say

Genpact's stock outlook is negatively influenced by challenges related to employee retention in key markets, which may hinder revenue growth. Additionally, macroeconomic shocks, exemplified by events like the Covid-19 pandemic, are anticipated to slow client decision-making processes, further impacting Genpact's financial performance. Furthermore, adverse currency fluctuations pose a risk to both the company's revenue and net income, adding to the pressures on its overall financial health.

Genpact (G) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 0% recommend Buy, 71% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Genpact and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Genpact (G) Forecast

Analysts have given Genpact (G) a Buy based on their latest research and market trends.

According to 7 analysts, Genpact (G) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $49.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $49.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Genpact (G)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.